• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HER2 过表达的经典型浸润性小叶癌:临床、组织学和激素受体特征。

Classical-type invasive lobular carcinoma with HER2 overexpression: clinical, histologic, and hormone receptor characteristics.

机构信息

Department of Pathology, Magee-Womens Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.

出版信息

Am J Clin Pathol. 2011 Jul;136(1):88-97. doi: 10.1309/AJCP7URIW0QETTAT.

DOI:10.1309/AJCP7URIW0QETTAT
PMID:21685036
Abstract

The majority of invasive lobular carcinomas (ILCs) express estrogen receptor (ER) and progesterone receptor (PR) but lack ERBB2 (HER2) amplification. HER2 overexpression is traditionally considered to occur in the pleomorphic variant of ILCs. We describe 12 cases of classical-type ILCs with HER2 overexpression in a 3-year period. All tumors displayed the characteristic morphologic features of classical ILC with uniform cells and discohesive growth patterns. The lobular phenotype was confirmed by the absence of E-cadherin staining. Multiple variables regarding clinical, histologic, and hormone receptor characteristics of tumors were evaluated and compared with a set of HER2- classical ILCs. The study identified 2 main pathologic features associated with HER2 overexpression in classical type ILC: histiocytoid morphologic features and absence of PR expression. ER is still expressed in HER2+ classical ILCs, although the level of expression is significantly reduced compared with the HER2- cases. The implications of the findings are discussed.

摘要

大多数浸润性小叶癌(ILC)表达雌激素受体(ER)和孕激素受体(PR),但缺乏 ERBB2(HER2)扩增。HER2 过表达传统上被认为发生在 ILC 的多形性变体中。我们描述了在 3 年内出现 HER2 过表达的 12 例经典型 ILC。所有肿瘤均表现出具有均匀细胞和离散生长模式的经典 ILC 的特征形态特征。通过缺乏 E-钙黏蛋白染色来确认小叶表型。评估了与肿瘤的临床、组织学和激素受体特征有关的多个变量,并与一组 HER2-经典 ILC 进行了比较。研究确定了与经典型 ILC 中 HER2 过表达相关的 2 个主要病理特征:组织细胞样形态特征和 PR 表达缺失。虽然与 HER2-病例相比,HER2+经典 ILC 中 ER 的表达水平显著降低,但仍有表达。讨论了这些发现的意义。

相似文献

1
Classical-type invasive lobular carcinoma with HER2 overexpression: clinical, histologic, and hormone receptor characteristics.HER2 过表达的经典型浸润性小叶癌:临床、组织学和激素受体特征。
Am J Clin Pathol. 2011 Jul;136(1):88-97. doi: 10.1309/AJCP7URIW0QETTAT.
2
The expression of cytokeratin 5/6 in invasive lobular carcinoma of the breast: evidence of a basal-like subset?细胞角蛋白5/6在乳腺浸润性小叶癌中的表达:存在基底样亚型的证据?
Hum Pathol. 2008 Mar;39(3):331-6. doi: 10.1016/j.humpath.2007.07.014.
3
The effect of prolonged fixation on the immunohistochemical evaluation of estrogen receptor, progesterone receptor, and HER2 expression in invasive breast cancer: a prospective study.长时间固定对浸润性乳腺癌中雌激素受体、孕激素受体和 HER2 表达的免疫组织化学评估的影响:一项前瞻性研究。
Am J Surg Pathol. 2011 Apr;35(4):545-52. doi: 10.1097/PAS.0b013e31820e6237.
4
Coordinated expression of ER, PR and HER2 define different prognostic subtypes among poorly differentiated breast carcinomas.雌激素受体(ER)、孕激素受体(PR)和人表皮生长因子受体2(HER2)的协同表达在低分化乳腺癌中定义了不同的预后亚型。
Histopathology. 2009 Sep;55(3):346-52. doi: 10.1111/j.1365-2559.2009.03380.x.
5
Histologic subtypes of invasive lobular carcinoma in correlation with tumor status and hormone receptors.浸润性小叶癌的组织学亚型与肿瘤状态及激素受体的相关性
Acta Clin Croat. 2010 Sep;49(3):275-81.
6
Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile.乳腺粗针穿刺活检中的多形性小叶原位癌(PLCIS):临床意义及免疫表型
Am J Surg Pathol. 2008 Nov;32(11):1721-6. doi: 10.1097/PAS.0b013e31817dc3a6.
7
Discordant expression of hormone receptors and HER2 in breast cancer. A retrospective comparison of primary tumors with paired metachronous recurrences or metastases.乳腺癌中激素受体与HER2的不一致表达。原发性肿瘤与配对的异时复发或转移灶的回顾性比较。
J BUON. 2012 Apr-Jun;17(2):277-83.
8
Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.三阴性乳腺癌中的大汗腺癌:大汗腺型浸润性导管癌为雌激素/孕激素受体阴性、雄激素受体阳性的新型定义。
Jpn J Clin Oncol. 2012 May;42(5):375-86. doi: 10.1093/jjco/hys034. Epub 2012 Mar 26.
9
Expression of E-cadherin and c-erbB-2/HER-2/neu oncoprotein in high-grade breast cancer.E-钙黏蛋白和c-erbB-2/HER-2/neu癌蛋白在高级别乳腺癌中的表达
Cesk Patol. 2007 Jul;43(3):87-92.
10
Seven-year survey of classical and pleomorphic invasive lobular breast carcinomas in women from southeastern Serbia: Differences in clinicopathological and immunohistochemical features.塞尔维亚东南部女性经典型和多形性浸润性小叶乳腺癌的七年调查:临床病理和免疫组化特征的差异
J BUON. 2016 Sept-Oct;21(5):1113-1120.

引用本文的文献

1
Clinicopathological Features of HER2 Expressing Lobular Carcinoma of Breast.人表皮生长因子受体2(HER2)表达的乳腺小叶癌的临床病理特征
World J Oncol. 2025 Jul 8;16(4):357-364. doi: 10.14740/wjon2588. eCollection 2025 Aug.
2
Invasive lobular carcinoma with metastasis to the pectoralis muscle.浸润性小叶癌伴胸大肌转移。
Radiol Case Rep. 2025 Apr 5;20(6):3129-3133. doi: 10.1016/j.radcr.2025.03.051. eCollection 2025 Jun.
3
Unique Molecular Alteration of Lobular Breast Cancer: Association with Pathological Classification, Tumor Biology and Behavior, and Clinical Management.
小叶型乳腺癌的独特分子改变:与病理分类、肿瘤生物学行为及临床管理的关联
Cancers (Basel). 2025 Jan 27;17(3):417. doi: 10.3390/cancers17030417.
4
Evaluation of HER2 Positivity Based on Clinicopathological Findings in HER2 Borderline Tumors in Iranian Patients with Breast Cancer.基于临床病理特征评估伊朗乳腺癌患者HER2临界肿瘤中HER2的阳性情况。
Iran J Pathol. 2023;18(4):403-409. doi: 10.30699/IJP.2023.561915.2970. Epub 2023 Oct 15.
5
Lobular Carcinoma of the Breast: A Comprehensive Review with Translational Insights.乳腺小叶癌:一项具有转化性见解的综合综述
Cancers (Basel). 2023 Nov 20;15(22):5491. doi: 10.3390/cancers15225491.
6
HER2-positive invasive lobular carcinoma: a rare breast cancer which may not necessarily require anti-HER2 therapy. A population-based study.人表皮生长因子受体2阳性浸润性小叶癌:一种罕见的乳腺癌,不一定需要抗人表皮生长因子受体2治疗。一项基于人群的研究。
Breast Cancer. 2023 May;30(3):343-353. doi: 10.1007/s12282-022-01432-3. Epub 2023 Jan 30.
7
Invasive lobular carcinoma: an understudied emergent subtype of breast cancer.浸润性小叶癌:一种研究不足的乳腺癌新兴亚型。
Breast Cancer Res Treat. 2022 Jun;193(2):253-264. doi: 10.1007/s10549-022-06572-w. Epub 2022 Mar 26.
8
Histiocytoid variant of invasive lobular breast carcinoma. A case report and literature review.浸润性小叶癌的组织细胞样变异型。病例报告及文献复习。
Ann Med Surg (Lond). 2021 Nov 18;72:103091. doi: 10.1016/j.amsu.2021.103091. eCollection 2021 Dec.
9
Lobular Breast Cancer: Histomorphology and Different Concepts of a Special Spectrum of Tumors.小叶性乳腺癌:肿瘤特殊谱系的组织形态学及不同概念
Cancers (Basel). 2021 Jul 22;13(15):3695. doi: 10.3390/cancers13153695.
10
HER2 Positive and HER2 Negative Classical Type Invasive Lobular Carcinomas: Comparison of Clinicopathologic Features.HER2 阳性和 HER2 阴性经典型浸润性小叶癌:临床病理特征比较。
Curr Oncol. 2021 Apr 24;28(3):1608-1617. doi: 10.3390/curroncol28030150.